Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver
- 21 February 2022
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 6 (2) , 157-167
Abstract
Systemically delivered lipid nanoparticles are preferentially taken up by hepatocytes. This hinders the development of effective, non-viral means of editing genes in tissues other than the liver. Here we show that lipid-nanoparticle-mediated gene editing in the lung and spleen of adult mice can be enhanced by reducing Cas9-mediated insertions and deletions in hepatocytes via oligonucleotides disrupting the secondary structure of single-guide RNAs (sgRNAs) and also via their combination with short interfering RNA (siRNA) targeting Cas9 messenger RNA (mRNA). In SpCas9 mice with acute lung inflammation, the systemic delivery of an oligonucleotide inhibiting an sgRNA targeting the intercellular adhesion molecule 2 (ICAM-2), followed by the delivery of the sgRNA, reduced the fraction of ICAM-2 indels in hepatocytes and increased that in lung endothelial cells. In wild-type mice, the lipid-nanoparticle-mediated delivery of an inhibitory oligonucleotide, followed by the delivery of Cas9-degrading siRNA and then by Cas9 mRNA and sgRNA, reduced the fraction of ICAM-2 indels in hepatocytes but not in splenic endothelial cells. Inhibitory oligonucleotides and siRNAs could be used to modulate the cell-type specificity of Cas9 therapies.Keywords
This publication has 62 references indexed in Scilit:
- Safety profile of RNAi nanomedicinesAdvanced Drug Delivery Reviews, 2012
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Designing Chemically Modified Oligonucleotides for Targeted Gene SilencingChemistry & Biology, 2012
- Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid CellsMolecular Therapy Nucleic Acids, 2012
- Rational design of cationic lipids for siRNA deliveryNature Biotechnology, 2010
- Lipid-like materials for low-dose, in vivo gene silencingProceedings of the National Academy of Sciences, 2010
- Stability Study of Unmodified siRNA and Relevance to Clinical UseOligonucleotides, 2008
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007
- Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imagingNucleic Acids Research, 2006
- Mouse Eotaxin Expression Parallels Eosinophil Accumulation during Lung Allergic Inflammation but It Is Not Restricted to a Th2-Type ResponseImmunity, 1996